J&J's propofol administration device finally wins FDA nod

Johnson & Johnson ($JNJ) won FDA approval for its Sedasys device to administer the sedative propofol, often used in colonoscopy patients, without the need for ongoing monitoring by an anesthesiologist. Release | Report